Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Healthcare
/
Teleflex
TFX
Teleflex
Tariffs And Pricing Pressures Will Squeeze Margins Yet Unlock Value
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 9 Analysts
Published
22 Apr 25
Updated
23 Jul 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$123.00
5.8% undervalued
intrinsic discount
23 Jul
US$115.89
Loading
1Y
-50.3%
7D
0.3%
Author's Valuation
US$123.0
5.8% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
1
Shared on
07 May 25
Fair value Decreased 8.89%
Read more
0
votes
Share
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$123.0
5.8% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
3b
2014
2017
2020
2023
2025
2026
2028
Revenue US$3.3b
Earnings US$322.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
6.71%
Medical Equipment revenue growth rate
0.32%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
7.88%
Calculation
US$322.86m
Earnings '28
x
17.22x
PE Ratio '28
=
US$5.56b
Market Cap '28
US$5.56b
Market Cap '28
/
36.45m
No. shares '28
=
US$152.55
Share Price '28
US$152.55
Share Price '28
Discounted to 2025 @ 7.89% p.a.
=
US$121.48
Fair Value '25
